Biophytis Sa Is A Clinical Stage Biotechnology Company Based In Azle De Francefrancefounded In 2006The Company Focuses On Developing Therapeutics Aimed At Slowing Degenerative Processes Associated With Agingwith A Team Of 11 To 50 Employeesbiophytis Is Dedicated To Enhancing Biological Resilience To Stress During Aging Through Its Small Molecule Drug Candidates The Company Is Advancing Several Drug Candidatesincluding Ruvembribio101 Which Is In Late Stage Clinical Development For Severe Covid 19 Respiratory Complicationssarcopenia Related Mobility Lossand Duchenne Muscular Dystrophydmd Other Candidates Include Sarconeosbio101For Sarcopenic Obesity And Macuneosbio201Targeting Dry Age Related Macular Degenerationamd Biophytis Collaborates With Academic Institutions And Pharmaceutical Partners To Further Develop Its Technologies After Achieving Clinical Proof Of Concept
